Publications by authors named "Ligia Miranda"
Article Synopsis
- - The study aimed to evaluate how cost-effective L-AmB is compared to Sb and AmB-D for treating mucocutaneous leishmaniasis in a Brazilian hospital from 2006-2012.
- - Results showed that L-AmB had a significantly higher treatment completion rate (82.2%) after 2 months and 100% after 12 months, compared to Sb (22.0% after 2 months, 72.2% after 12 months) and AmB-D (19.9% after 2 months, 77.4% after 12 months).
- - Although L-AmB is more expensive (costing around US$ 11,337.44), its higher
Introduction: The treatment of fungal infections in severely ill patients is a clinical and economic challenge worldwide. Liposomal amphotericin B and caspofungin are highly effective antifungal drugs; however, they are very expensive and health systems must select the drug that results in the best clinical outcomes and is economically feasible.
Areas Covered: A systematic search was conducted in PubMed, Scopus, Web of Science, Cochrane Library, Health Economic Evaluation Database, and Centre for Review and Dissemination to find complete economic evaluations that directly compared the two treatment strategies.